Start Date
December 31, 2013
Primary Completion Date
December 31, 2016
IPI-145
75 mg orally twice daily for 4 weeks.
Follow-up Visit/Call
Follow-up visit 30 days after last dose of study drug. If patient cannot make it to the clinic for this visit, they may speak by phone with a member of the study staff. This phone call should last about 10 minutes.
Collaborators (1)
Infinity Pharmaceuticals, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER